Who owns VISTAGEN THERAPEUTICS ORD?
- Ticker: VTGN
- CUSIP Number: 92840h400
Tip: Access positions for across all investors
Analyze quarterly positions in Vistagen Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vistagen Therapeutics Ord stock
Who bought or sold VISTAGEN THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 2.0M | $10M | 100% | Dec 2023 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.9M | $9.6M | 100% | Dec 2023 |
|
| Vanguard Group | 1.8M | $9.4M | 623% | Dec 2023 |
|
| Nantahala Capital Management | 1.8M | $9.3M | 100% | Dec 2023 |
|
| Commodore Capital | 1.6M | $8.1M | 0% | Dec 2023 |
|
| Citadel Advisors | 817k | $4.2M | 1095% | Dec 2023 |
|
| Sphera Funds Management | 809k | $4.2M | 709% | Dec 2023 |
|
| ADAR1 Capital Management | 246k | $1.3M | 100% | Dec 2023 |
|
| Two Sigma Investments | 192k | $987k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 164k | $842k | 100% | Dec 2023 |
|
| BML Capital Management | 150k | $792k | 0% | Mar 2024 |
|
| Bank Of Montreal | 97k | $524k | 100% | Dec 2023 |
|
| William Blair $ Company | 88k | $453k | 3% | Dec 2023 |
|
| Gts Securities | 85k | $439k | 100% | Dec 2023 |
|
| Citigroup | 58k | $300k | 142283% | Dec 2023 |
|
| DAFNA Capital Management | 42k | $215k | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 23k | $120k | 100% | Dec 2023 |
|
| Barclays | 23k | $119k | 100% | Dec 2023 |
|
| Jane Street | 22k | $113k | 100% | Dec 2023 |
|
| Bank of America Corporation | 19k | $100k | 2965% | Dec 2023 |
|
| Virtu Financial | 16k | $80k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 11k | $54k | 117% | Dec 2023 |
|
| Janney Montgomery Scott | 10k | $51k | 100% | Dec 2023 |
|
| GPS Wealth Strategies Group | 8.4k | $43k | 0% | Dec 2023 |
|
| CWM | 2.4k | $13k | -1% | Mar 2024 |
|
| Royal Bank of Canada | 1.4k | $7.0k | -50% | Dec 2023 |
|
| BFSG | 1.0k | $5.3k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 208.00 | $1.1k | 206% | Dec 2023 |
|
| UBS Group | 117.00 | $601.005600 | -92% | Dec 2023 |
|
| EverSource Wealth Advisors | 88.00 | $452.003200 | 0% | Dec 2023 |
|
| Fairman Group | 29.00 | $148.999100 | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 16.00 | $82.000000 | 0% | Dec 2023 |
|
Who sold out of Vistagen Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ikarian Capital | Sep 2023 | 229k | $1.2M |
| Schonfeld Strategic Advisors | Sep 2023 | 139k | $726k |
| GSA Capital Partners | Sep 2023 | 47k | $245k |
| Millennium Management | Sep 2023 | 17k | $88k |
| Bank of New York Mellon | Dec 2023 | 15k | $78k |
| Simplex Trading | Dec 2023 | 12k | $63k |
| Cutler | Dec 2023 | 200.00 | $1.0k |